Three new quinazolinobenzodiazepine derivatives, novobenzomalvins A (1), B (2), and C (3), have been isolated as fibronectin expression regulators from Aspergillus novofumigatus CBS117520. The structures of 1 to 3 were established by spectroscopic and physicochemical analysis, and chemical investigation including the total synthesis of 1. Treatment with novo-benzomalvins A (1), B (2), C (3), and N-methylnovobenzomalvin A (5) increased the expression of fibronectin in normal human neonatal dermal fibroblast cells. © Ishikawa et al.
CITATION STYLE
Ishikawa, K., Hosoe, T., Itabashi, T., Sato, F., Wachi, H., Nagase, H., … Kawai, K. I. (2011). Quinazolinobenzodiazepine derivatives, novobenzomalvins A-C: Fibronectin expression regulators from Aspergillus novofumigatus. Scientia Pharmaceutica, 79(4), 937–950. https://doi.org/10.3797/scipharm.1106-21
Mendeley helps you to discover research relevant for your work.